Profund Advisors LLC Bluebird Bio, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.32 - $4.83 $10,463 - $38,287	-7,927 Reduced 3.66%	208,439 $287,000
Q3 2023 Nov 13, 2023	SELL	$3.02 - $4.05 $236,511 - $317,175	-78,315 Reduced 26.58%	216,366 $657,000
Q2 2023 Aug 10, 2023	SELL	$2.79 - $5.03 $6,520 - $11,755	-2,337 Reduced 0.79%	294,681 $969,000
Q1 2023 May 11, 2023	BUY	$3.14 - $8.22 $932,636 - $2.44 Million	297,018 New	297,018 $944,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $151,683 - $283,395	-13,495 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$18.04 - $22.09 $30,054 - $36,801	1,666 Added 14.08%	13,495 $432,000
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $28,086 - $57,375	-1,693 Reduced 12.52%	11,829 $357,000
Q4 2020 Feb 09, 2021	BUY	$27.5 - $37.92 $33,302 - $45,921	1,211 Added 9.84%	13,522 $585,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $70,188 - $89,162	-2,038 Reduced 14.2%	12,311 $664,000
Q2 2020 Aug 03, 2020	BUY	$27.12 - $45.97 $107,151 - $181,627	3,951 Added 38.0%	14,349 $876,000
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $99,172 - $240,728	-3,791 Reduced 26.72%	10,398 $478,000
Q4 2019 Feb 18, 2020	BUY	$46.96 - $61.67 $68,937 - $90,531	1,468 Added 11.54%	14,189 $1.25 Million
Q3 2019 Nov 12, 2019	SELL	$59.47 - $93.1 $51,025 - $79,879	-858 Reduced 6.32%	12,721 $1.17 Million
Q2 2019 Aug 13, 2019	SELL	$75.84 - $105.21 $131,354 - $182,223	-1,732 Reduced 11.31%	13,579 $1.73 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $17,914 - $28,942	278 Added 1.85%	15,311 $2.41 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $205,727 - $324,638	-3,481 Reduced 18.8%	15,033 $1.49 Million
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $260,804 - $344,833	2,935 Added 18.84%	18,514 $2.7 Million
Q2 2018 Aug 13, 2018	SELL	$99.64 - $127.59 $226,282 - $289,756	-2,271 Reduced 12.72%	15,579 $2.45 Million
Q1 2018 May 14, 2018	SELL	$105.8 - $150.94 $150,236 - $214,334	-1,420 Reduced 7.37%	17,850 $3.05 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $58,012 - $93,319	-714 Reduced 3.57%	19,270 $3.43 Million
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $190,715 - $301,960	3,303 Added 19.8%	19,984 $2.75 Million
Q2 2017 Aug 11, 2017	BUY	N/A	16,681	16,681 $1.75 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.88 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.73 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.73 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.42 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account